Property | Value |
Name | Detection of Extended spectrum β-lactamase, AmpC β-lactamase and Metallo β-lactamase in clinical isolates of Pseudomonas aeruginosa |
Description | Research article
1.Hancock RE, Speert DP.Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment.Drug Resist Updat. 2000 Aug;3(4):247-255..Pubmed, Web of science 2.Pier GB, Ramphal R. Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, Bennett’s Principles & practices of infectious diseases 6th ed. Elsevier:Churchill Livingstone; 2005 Vol 2. p. 2587-615. 3.Buchunde S, Mendriratta DK, Deotale V, Narang P. Comparison of disc and MIC reduction methods with PCR for the detection of Metallo beta-lactamase in Pseudomonas aeruginosa. Indian J Med Microbiol 2012; 30(2):170-4. Pubmed 4. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother. 2003 May;47(5):1681-8.Pubmed 5.Akhabue E, Synnestvedt M, Weiner MG, Bilker WB, Lautenbach E. Cefepime resistant Pseudomonas aeruginosa. Emerg Infect Dis 2011; 17(6):1037-43. Pubmed 6.Govan JRW. Pseudomonas, Stenotrophomonas, Burkholderia. In: Colle JG, Fraser AG, Marimon BP, Simmons A, eds. Mackie & McCartney Practical Medical Microbiology. 14th ed. London:Churchill Livingstone; 2006. p. 413-24. 7.Clinical and Laboratory Standards Institute (CLSI), Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement, M100-S20 2010; 30(1). 8. Jarlier V, Nicolas MH, Fournier G, Philippon A.Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.Rev Infect Dis. 1988 Jul-Aug;10(4):867-78.Pubmed 9.Sanders CC, Sanders WE, Goering HV. In vitro antagonism of beta-lactam antibiotics by cefoxitin. Antimicrob Agents Chemother 1982; 21:968-75.Pubmed 10.Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromasomal AmpC beta-lactamases. J Clin Microbiol 2005; 43(7):3110-13.Pubmed 11.Manchanda V, Singh NP. Occurrence and detection of AmpC beta-lactamases among Gram negative clinical isolates using a modified three dimensional test at Guru Tegh Bahadur Hospital, Delhi, India. J Antimicrob Chemother 2003; 51:415-8.Pubmed 12.Yong D, Lee K, Yum JH, Shin FB, Rossolini GM, Chong Y. Imipenem- EDTA disc method for differentiation of metallo-beta-lactamase producing clinical isolates of Pseudomonas species and Acinetobacter species. J Clin Microbiol 2002; 40:3798-801.Pubmed 13.Somily AM, Absar MM, Arshad MZ, Al Aska AI, Shakoor ZA, Fatani AJ, Siddiqui YM, Murray TS.Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.Saudi Med J. 2012 Jul;33(7):750-5.Pubmed 14.Varaiya A, Kulkarni M, Bhalekar P, Dogra J. Incidence of metallo-beta-lactamase producing Pseudomonas aeruginosa in diabetes and cancer patients. Indian J Pathol Microbiol 2008; 51(2):200-3.Pubmed 15.Gupta V. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Opin Investig Drugs 2008; 17(2):131-43.Pubmed 16.Aggarwal R, Chaudhary U, Bala K. Detection of extended spectrum beta-lactamases in Pseudomonas aeruginosa. Indian J Pathol Microbiol 2008; 51(2):222-24.Pubmed 17.Sevillano E, Valderrey C, Canduela MJ, Umaran A, Calvo F, Gallego L. Resistance to antibiotics in clinical isolates of Pseudomonas aeruginosa. Pathol Biol 2006; 54:493-7.Pubmed 18.Gencer S, Akoznur, Benzonana N, Batirel A, Ozer S. Susceptibility pattern and cross resistance of antibiotic against Pseudomonas aeruginosa in a teaching hospital of Turkey. Ann Clin Microbiol Antimicrobial 2002; 1:2. doi:10.1186/1476-0711-1-2.Pubmed 19.Blandino G, Marchese A, Ardito F, Fadda G, Fontana R, Lo Cascio G, Marchetti F, Schito GC, Nicoletti G.Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections.Int J Antimicrob Agents. 2004 Nov;24(5):515-8.Pubmed 20.Diwivedi M, Mishra A, Singh RK, Azim A, Baronia AK, Prasad KN. The nosocomial cross- transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Indian J Pathol Microbiol 2009; 52(4):509-13.Pubmed 21. Picão RC, Poirel L, Gales AC, Nordmann P.Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil.Antimicrob Agents Chemother. 2009 Sep;53(9):3908-13. doi: 10.1128/AAC.00453-09. Epub 2009 Jul 13.Pubmed 22.Tawfik AF, Shibl AM, Aljohi MA, Altammami MA, Al- Agamy MH. Distribution of Ambler Class A, B and D beta-lactamases among Pseudomonas aeruginosa isolates. Burns 2012; 38(6):855-60.Pubmed 23.Upadhyay S, Ranjan M, Bhattacharjee. Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressing Amp C beta-lactamase enzyme. J Infect Dev Ctries 2010; 4(4):239-42.Pubmed 24.Umadevi S, Joseph NM, Kumari K, Easow JM, Kumar S, Stephan S. Detection of extended spectrum beta-lactamases, AmpC beta-lactamases and Metallo-beta-lactamases in clinical isolates of ceftazidime resistant Pseudomonas aeruginosa. Braz J Microbiol 2011; 42:1284-88. 25.Bradford PA. Extended spectrum beta-lactamases in the 21st century: characterization, epidemiology and detection of this important resistance threat. Clin Microbiol Rev 2001; 14(4):933-51.Pubmed 26.Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39:1211-33.Pubmed 27.Mohamudha R, Harish BN, Parija SC. AmpC beta-lactamases among Gram negative clinical isolates from a tertiary hospital, South India. Braz J Microbiol 2010; 41:596-602.Link 28.Jacoby GA. AmpC beta-lactamases. Clin Microbiol Rev 2009; 22:161-82.Pubmed 29.Wolska K. Identification of AmpC beta-lactamases in clinical Pseudomonas aeruginosa strains. Adv Clin Exp Med 2008; 17(5):519-23. 30.Hernández-Allés S, Benedí VJ, Martínez-Martínez L, Pascual A, Aguilar A, Tomás JM, Albertí S.Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genes.Antimicrob Agents Chemother. 1999 Apr;43(4):937-9.Pubmed 31.Behara B, Mathur P, Das A, Kapil A, Sharma V. An evaluation of four different phenotypic techniques for detection of Metallo-beta-lactamase producing Pseudomonas aeruginosa. Indian J Med Microbiol 2008; 26(3):233-7.Pubmed 32.Bush K. Metallo-beta-lactamase: a class apart. Clin Infect Dis 1998; 27(Suppl 1):S48-53.Pubmed 33.Navneeth BV, Sridaran D, Sahay D, Belwadi MR. Preliminary study on Metallo-beta-lactamase producing Pseudomonas aeruginosa in hospital patients. Indian J Med Res 2002; 116:264-7.Pubmed 34.Kumar SH, De AS, Baveja SM, Gore MA. Prevalence and risk factors of Metallo-beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in burns and surgical wards in a tertiary care hospital. J Lab Physicians 2012; 4(1):39-42.Pubmed 35.Jazani NH, Zahedi A, Garebagi N. Phenotypic detection of Metallo-beta-lactamase producing Pseudomonas aeruginosa isolated from Urmia hospital. Afr J Microbiol Res 2012; 6(7):1387-92.Link 36.Khuntayaporn P, Montakantikul P, Mootsikapun P, Thamlikutkal V, Chomnawang MT. Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant Pseudomonas aeruginosa in tertiary hospital across Thailand. Ann Clin Microbiol Antimicrob 2012; 11:25. doi: 10.1186/1476-0711-11-25. 37.Johann DD, Pitout DB, Poirel L, Mc Clure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa producing metallo-beta-lactamases in a large, centralized laboratory. J Clin Microbiol 2005; 43(7):3129-35.Pubmed 38.Soparsi S, Lutitanond A, Sribenjalux P, Wilailuckana C. Evaluation of phenotypic tests for detection of metallo-beta-lactamases in clinical isolates of Pseudomonas aeruginosa from Srinagarind Hospital. J Med Technol Phys Ther 2008; 20:3. 39.Manoharan A, Chatterjee S, Mathai D, SARI study group. Detection and characterization of metallo-beta-lactamase producing Pseudomonas aeruginosa. Indian J Med Microbiol 2010; 28:241-4.Pubmed |
Filename | Padiyath Sreeshma(1506-1515).pdf |
Filesize | 1.06 MB |
Filetype | pdf (Mime Type: application/pdf) |
Creator | admin |
Created On: | 08/07/2013 00:00 |
Viewers | Everybody |
Maintained by | Editor |
Hits | 4318 Hits |
Last updated on | 09/07/2013 10:15 |
Homepage | |
CRC Checksum | |
MD5 Checksum |